BioMarin Pharmaceutical(BMRN) - 2023 Q4 - Annual Report
BioMarin Pharmaceutical(BMRN)2024-02-25 16:00
BRINEURA is approved for marketing in the U.S. (for ages three and older) and in the EU (for all ages from birth) and in other international markets. ALDURAZYME ALDURAZYME is a highly purified protein that is designed to be identical to a naturally occurring form of the human enzyme alphaL-iduronidase, a lysosomal enzyme normally required for the breakdown of GAGs. MPS I is a progressive and debilitating life-threatening genetic disease that is caused by the deficiency of alpha-L-iduronidase. Patients with ...